- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/761 - Adenovirus
Patent holdings for IPC class A61K 35/761
Total number of patents in this class: 1120
10-year publication summary
|
53
|
105
|
120
|
137
|
130
|
150
|
87
|
102
|
82
|
46
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4426 |
43 |
| The Regents of the University of California | 20802 |
24 |
| Akamis bio, Inc. | 33 |
24 |
| The Salk Institute for Biological Studies | 448 |
20 |
| Takeda Pharmaceutical Company Limited | 2712 |
18 |
| Genemedicine Co., Ltd. | 32 |
17 |
| Tilt Biotherapeutics Oy | 31 |
17 |
| Psioxus Therapeutics Limited | 27 |
16 |
| University of Florida Research Foundation, Inc. | 4184 |
15 |
| Adverum Biotechnologies, Inc. | 107 |
14 |
| City of Hope | 1040 |
13 |
| Epicentrx, Inc. | 84 |
13 |
| Mayo Foundation for Medical Education and Research | 3389 |
12 |
| Hangzhou Converd Co., Ltd. | 36 |
11 |
| CG Oncology, Inc. | 27 |
11 |
| Beth Israel Deaconess Medical Center, Inc. | 853 |
10 |
| Janssen Vaccines & Prevention B.V. | 270 |
10 |
| Research Institute at Nationwide Children's Hospital | 642 |
10 |
| Centre National de La Recherche Scientifique | 11055 |
9 |
| Kagoshima University | 327 |
8 |
| Other owners | 805 |